Orphenadrine Citrate
Product Images NDC 66336-554

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 66336-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4ed1b591-figure-01 (4ed1b591 Figure 01)

Chemical structure diagram displaying the molecular arrangement of orphenadrine citrate, the active ingredient in the product. It shows the orphenadrine molecule linked with the citrate ion, illustrating their chemical configuration.*

FDA Label Image

Ndc 66336-0554-xx (Ndc 66336 0554 Xx Novel)

Label for Orphenadrine Citrate ER 100 mg tablets showing the product name, extended-release formulation, and NDC 66336-0554-XX. The label includes dosing instructions, warnings about drowsiness and alcohol avoidance, lot number, expiration date, and Rx-only status. The label shows manufacturer details for Dispensing Solutions, Inc., Santa Ana, CA, and bulk source data from Novel Laboratories, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.